Prof. Dr. Kadriye Kart Yaşar
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
COVID-19 22 publicationsSource: OpenAlex / PubMed MeSHView publications
- Tuberculosis, Meningeal 10 publications
- HIV Infections 7 publications
- Bacteremia 3 publications
- Pneumonia, Viral 3 publications
- Coronavirus Infections 3 publications
- Diabetic Foot 3 publications
- Cross Infection 2 publications
- Gram-Negative Bacterial Infections 2 publications
- Staphylococcal Infections 2 publications
- Influenza, Human 2 publications
- Streptococcal Infections 2 publications
- Hydrocephalus 2 publications
- Brucellosis 2 publications
- Brain Diseases 2 publications
- Nervous System Diseases 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyInfectious Diseases and Clinical Microbiologysaglik.gov.trFrom source
- Department name at the sourceEnfeksiyon Hast. ve Klinik Mikrobiyolojisaglik.gov.trFrom source
- InstitutionBakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
- Area of workCOVID-19Extracted from 22 publications · Model version —From source
- Publications173 publicationsOpenAlex, ORCID, Europe PMCFrom source
- ORCID0000-0003-2963-4894ORCIDFrom source
- Last synchronised5 November 2026 08:55https://bakirkoysadikonukeah.saglik.gov.tr/TR-1482116/doktorlarimiz.html#kadriye-kart-yasarsaglik.gov.tr
Scientific work
Publications on COVID-19
-
Epidemiological characteristics, genotype patterns, and treatment outcomes in chronic hepatitis C patients receiving direct-acting antivirals: a cohort study from Istanbul, Türkiye
BMC Infectious Diseases, 2026
DOI 10.1186/s12879-026-12850-5 PMID 41680668 1 citation (Europe PMC) Open-access full textSource: OpenAlex
-
Tenofovir Disoproxil Fumarate and Entecavir in Patients with Chronic Hepatitis B: Efficacy and Safety Comparison
Viral Hepatitis Journal, 2026
DOI 10.4274/vhd.galenos.2026.2025-12-3 Open-access full textSource: OpenAlex
-
Early diagnosis and risk groups: comorbidities in newly diagnosed adults with HIV in Turkey
Central European Journal of Public Health, 2026
DOI 10.21101/cejph.a8538 PMID 41973058 Source: OpenAlex
-
Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients
Frontiers in Nutrition, 2026
DOI 10.3389/fnut.2026.1836021 PMID 42325512 Open-access full textSource: OpenAlex
-
Temporal changes in mortality and risk factors of candidemia in intensive care unit patients
BMC Infectious Diseases, 2026
DOI 10.1186/s12879-026-13759-9 PMID 42251279 Open-access full textSource: ORCID
-
Evaluation of bloodstream infections in febrile neutropenic patients with hematological malignancy: a retrospective cohort study
BMC Infectious Diseases, 2026
DOI 10.1186/s12879-026-13465-6 PMID 42056949 2 citations (Europe PMC) Open-access full textSource: ORCID
-
Clinical and laboratory predictors of mortality in Staphylococcus aureus bacteremia
Scientific Reports, 2025
DOI 10.1038/s41598-025-16137-8 PMID 40841738 2 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Assessing Liver Fibrosis in Chronic Hepatitis B: Liver Biopsy or Non-Invasive Fibrosis Markers?
Journal of Clinical Medicine, 2025
DOI 10.3390/jcm14228164 PMID 41303199 2 citations (Europe PMC) Open-access full textSource: OpenAlex
-
The Influence of Characteristics and Indexes (NLR, PNI, and SII) Evaluated at Admission on the Mortality Prediction of Infectious Endocarditis Patients
International journal of general medicine, 2025
DOI 10.2147/ijgm.s535813 PMID 40988761 5 citations (Europe PMC) Open-access full textSource: Europe PMC
-
The effect of vitamin K1 and vitamin K2 on mortality rate and disease severity in COVID-19 patients: An observational study
Journal of Surgery and Medicine, 2025
DOI 10.28982/josam.8106 Open-access full textSource: ORCID